Opportunity Information: Apply for PAR 18 118
The NCCIH Mind and Body Clinical Trial Cooperative Agreement (U01 Clinical Trial Required), Funding Opportunity Number PAR 18-118, is a National Institutes of Health (NIH) discretionary funding opportunity from the National Center for Complementary and Integrative Health (NCCIH) under the health activity category (CFDA 93.213). It supports investigator-initiated clinical trials focused on mind and body interventions that align with NCCIH-designated areas of high research priority. The award mechanism is a cooperative agreement (U01), which typically means the funded project is carried out with substantial scientific and/or programmatic involvement from NIH staff compared to a standard research grant, while still remaining investigator-led.
The central purpose of this FOA is to move promising mind and body interventions toward the next stage of rigorous testing by funding clinical trials that refine, optimize, and strengthen the evidence base needed before launching a larger, definitive multi-site trial. Proposed studies are expected to do more than simply ask whether an intervention works. Instead, they should be designed to develop and test adaptive interventions, optimize complex interventions by identifying which components are truly driving changes in outcomes, and/or demonstrate that an intervention can be delivered consistently (with fidelity) across more than one site in a way that would support a future large-scale trial. Another allowable direction is collecting key preparatory preliminary data that would reduce uncertainty in a later multi-site study, such as determining the most appropriate intervention dose, duration, or frequency.
A major emphasis of the announcement is readiness. Applicants are expected to already have solid preliminary data in hand showing that the proposed work is feasible and that the intervention has credible promise of clinical benefit. The FOA explicitly points to the kinds of readiness evidence reviewers will expect, including proof that recruitment and accrual are workable, that participants can and will adhere to the intervention protocol, and that retention is strong enough to complete the study and final outcome data collection. It also stresses that any related or precursor studies should have completed final data collection, reinforcing the expectation that the fieldwork is mature enough to justify a cooperative agreement clinical trial rather than an early exploratory project.
This FOA is also clear about what it does not fund. It is not intended to support full-scale multi-site efficacy or effectiveness trials, meaning it is not meant to be the final, definitive trial intended to change clinical practice on its own. It also will not support clinical trials testing mind and body interventions for the treatment or prevention of cancer, which would need to be pursued through other NIH or institute-specific opportunities.
Eligibility is broad and includes many common public, private, academic, nonprofit, and governmental applicant types. Eligible applicants listed include state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; and small businesses. The FOA also highlights additional eligible entities such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, U.S. territories or possessions, and even non-U.S. (foreign) organizations and regional organizations.
In terms of basic timeline metadata provided, the opportunity was created on 2017-11-02, and the original closing date shown is 2020-06-29. The excerpted source information does not provide an award ceiling or an expected number of awards, so those details would typically need to be confirmed in the full FOA or related NIH guide notices. Overall, this program is best understood as targeted support for well-prepared, investigator-initiated mind and body clinical trials that are specifically designed to optimize interventions and de-risk the design of a later, larger multi-site trial, rather than to conduct the definitive large trial itself.Apply for PAR 18 118
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "NCCIH Mind and Body Clinical Trial Cooperative Agreement (U01 Clinical Trial Required)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.213.
- This funding opportunity was created on 2017-11-02.
- Applicants must submit their applications by 2020-06-29. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: Prevention Research in Mid-Life Adults (R21 Clinical Trial Optional)
Previous opportunity: Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R21 Clinical Trial Optional)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 18 118
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 18 118) also looked into and applied for these:
| Funding Opportunity |
|---|
| Improving Outcomes for Disorders of Human Communication (R21 Clinical Trial Optional) Apply for PA 18 288 Funding Number: PA 18 288 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Population-based HIV Impact Assessments in Resource-Constrained Settings under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH14 1409A Funding Number: CDC RFA GH14 1409A Agency: Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Human Studies to Evaluate Promising Medications to Treat Alcohol Use Disorder (R03 Clinical Trial Required) Apply for PA 18 198 Funding Number: PA 18 198 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Human Studies to Evaluate Promising Medications to Treat Alcohol Use Disorder (R21 Clinical Trial Required) Apply for PA 18 197 Funding Number: PA 18 197 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Systems Biology Approaches using Non-Mammalian Laboratory Animals to Uncover Causes of Neurodegeneration that Might Underlie Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed) Apply for RFA AG 18 021 Funding Number: RFA AG 18 021 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R03 Clinical Trial Optional) Apply for PA 18 200 Funding Number: PA 18 200 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Alcohol Use Disorders: Behavioral Treatment, Services and Recovery Research (R03 Clinical Trial Optional) Apply for PA 18 201 Funding Number: PA 18 201 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Alcohol Use Disorders: Behavioral Treatment, Services and Recovery Research (R21 Clinical Trial Optional) Apply for PA 18 202 Funding Number: PA 18 202 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Human Studies to Evaluate Promising Medications to Treat Alcohol Use Disorder (R01 Clinical Trial Required) Apply for PA 18 192 Funding Number: PA 18 192 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R01 Clinical Trial Optional) Apply for PA 18 193 Funding Number: PA 18 193 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Alcohol Use Disorders: Behavioral Treatment, Services and Recovery Research (R01 Clinical Trial Optional) Apply for PA 18 194 Funding Number: PA 18 194 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R21 Clinical Trial Optional) Apply for PA 18 199 Funding Number: PA 18 199 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Mechanisms of Disparities for HIV- Related Co-morbidities in Health Disparity Populations (R01-Clinical Trial Not Allowed) Apply for RFA MD 18 002 Funding Number: RFA MD 18 002 Agency: National Institutes of Health Category: Health Funding Amount: $450,000 |
| NIMH Exploratory/Developmental Research Grant (R21 - Clinical Trial Not Allowed) Apply for PA 18 350 Funding Number: PA 18 350 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Selected Topics in Transfusion Medicine (R01 Clinical Trial Optional) Apply for PAR 18 126 Funding Number: PAR 18 126 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Translational Neural Devices (UG3/UH3 - Clinical Trial Required) Apply for RFA NS 18 011 Funding Number: RFA NS 18 011 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) Apply for PAR 18 174 Funding Number: PAR 18 174 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Selected Topics in Transfusion Medicine (R21 Clinical Trial Optional) Apply for PAR 18 132 Funding Number: PAR 18 132 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Translational Neural Devices (U44 - Clinical Trial Required) Apply for RFA NS 18 012 Funding Number: RFA NS 18 012 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01) (Clinical Trial Required) Apply for RFA HL 18 027 Funding Number: RFA HL 18 027 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 18 118", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
